1. Home
  2. HTLD vs DNA Comparison

HTLD vs DNA Comparison

Compare HTLD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$11.06

Market Cap

854.2M

Sector

Industrials

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$7.09

Market Cap

607.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTLD
DNA
Founded
1978
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
854.2M
607.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
HTLD
DNA
Price
$11.06
$7.09
Analyst Decision
Hold
Hold
Analyst Count
5
2
Target Price
$9.80
$10.50
AVG Volume (30 Days)
651.9K
1.2M
Earning Date
05-12-2026
01-01-0001
Dividend Yield
0.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$805,709,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.93
$3.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.00
$5.00
52 Week High
$12.13
$17.58

Technical Indicators

Market Signals
Indicator
HTLD
DNA
Relative Strength Index (RSI) 52.63 36.91
Support Level $8.31 $6.81
Resistance Level $12.13 $10.05
Average True Range (ATR) 0.46 0.72
MACD -0.11 -0.22
Stochastic Oscillator 35.91 17.07

Price Performance

Historical Comparison
HTLD
DNA

About HTLD Heartland Express Inc.

Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: